Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 08, 2021

SELL
$90.24 - $124.05 $180,209 - $247,727
-1,997 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$116.57 - $155.01 $34,621 - $46,037
297 Added 17.47%
1,997 $263,000
Q4 2020

Feb 02, 2021

BUY
$99.61 - $142.12 $169,337 - $241,604
1,700 New
1,700 $225,000
Q3 2019

Nov 05, 2019

SELL
$90.37 - $122.49 $153,629 - $208,233
-1,700 Closed
0 $0
Q2 2019

Jul 30, 2019

BUY
$89.51 - $118.04 $152,167 - $200,668
1,700 New
1,700 $201,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.93B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Grimes & Company, Inc. Portfolio

Follow Grimes & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.